| Study | Reason for exclusion |
|---|---|
| Abud 2016 | Ineligible study population |
| Acord 2010 | Ineligible study design (cross‐over trial, conference poster) |
| Asbell 2011 | Ineligible study design (workshop report) |
| Boynton 2015 | Ineligible study population |
| ChiCTR‐IPQ‐15006773 | Ineligible study design (quasi‐randomization) |
| Edward 2014 | Trial withdrawn by sponsor (before participant enrollment) |
| EUCTR2006‐003391‐35‐NL | Ineligible study design (within‐person comparison) |
| EUCTR2019‐000747‐27‐IT | Ineligible intervention (within‐person comparison) |
| Gupta 2021 | Ineligible study design (review article) |
| ISRCTN13765551 | Ineligible study design (same intervention, preservative‐free versus preserved formula) |
| Jee 2014 | Ineligible study design (same intervention, preservative‐free versus preserved formula) |
| JPRN‐UMIN000025159 | Ineligible study design (non‐pharmacological intervention) |
| Kallab 2020 | Ineligible study design (comparing dosing schedules) |
| Korenfeld 2021 | Ineligible study design (secondary data analysis) |
| Lee 2006 | Ineligible study design (within‐person comparison) |
| NCT03907865 | Ineligible study design (comparing dosing schedules) |
| Rolando 2008 | Ineligible study design (comparing dosing schedules) |
| Ryu 2005 | Ineligible study design (within‐person comparison) |
| Shen 2015 | Ineligible intervention (FML combined with contact lens) |
| Sindhu 2015 | Ineligible study design (observational study) |
| Wong 2021 | Ineligible study design (review article) |
FML, fluorometholone